HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans J Hansen Selected Research

Buffers

11/2008Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hans J Hansen Research Topics

Disease

23Neoplasms (Cancer)
10/2009 - 05/2002
9Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2009 - 08/2003
6Lymphoma (Lymphomas)
01/2009 - 05/2002
5Colonic Neoplasms (Colon Cancer)
11/2008 - 04/2005
3B-Cell Lymphoma (Lymphoma, B Cell)
02/2008 - 05/2002
3Burkitt Lymphoma (Burkitt's Lymphoma)
02/2008 - 12/2005
3Multiple Myeloma
09/2007 - 12/2004
3Neoplasm Metastasis (Metastasis)
01/2007 - 04/2005
2Carcinoma (Carcinomatosis)
10/2009 - 04/2005
1Multiple Sclerosis
01/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2009
1Autoimmune Diseases (Autoimmune Disease)
02/2007
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2007
1Prostatic Neoplasms (Prostate Cancer)
01/2007
1Neoplasm Micrometastasis
10/2005
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2005
1Residual Neoplasm
04/2005
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2004
1Breast Neoplasms (Breast Cancer)
03/2004
1Hematologic Neoplasms (Hematological Malignancy)
05/2002

Drug/Important Bio-Agent (IBA)

12Monoclonal AntibodiesIBA
09/2007 - 05/2002
10AntigensIBA
11/2008 - 01/2003
7AntibodiesIBA
02/2008 - 05/2002
7Radioisotopes (Radionuclides)IBA
09/2007 - 05/2002
6Peptides (Polypeptides)IBA
01/2012 - 05/2002
6Carcinoembryonic AntigenIBA
01/2007 - 09/2003
5Pharmaceutical PreparationsIBA
11/2008 - 12/2003
4Rituximab (Mabthera)FDA Link
01/2009 - 04/2004
4epratuzumabIBA
02/2007 - 08/2003
3Irinotecan (Camptosar)FDA LinkGeneric
10/2009 - 04/2005
3Immunoconjugates (Immunoconjugate)IBA
10/2009 - 07/2005
3Complement System Proteins (Complement)IBA
01/2009 - 04/2004
3Ribonucleases (Ribonuclease)IBA
09/2007 - 05/2002
3HaptensIBA
11/2005 - 09/2003
3Proteins (Proteins, Gene)FDA Link
10/2005 - 09/2003
2ProdrugsIBA
10/2009 - 11/2008
2veltuzumabIBA
01/2009 - 04/2004
2labetuzumabIBA
11/2008 - 04/2005
2milatuzumabIBA
09/2007 - 12/2004
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2007 - 07/2005
2HLA-DR Antigens (HLA-DR)IBA
10/2006 - 07/2005
2Immunotoxins (Immunotoxin)IBA
12/2005 - 05/2005
2Immunoglobulin G (IgG)IBA
12/2005 - 04/2005
2IodineIBA
04/2005 - 03/2004
2chloramine-T (Clorina)IBA
03/2004 - 01/2003
1Topoisomerase I InhibitorsIBA
11/2008
1BuffersIBA
11/2008
1IsotopesIBA
09/2007
1EpitopesIBA
10/2005
1IMMU-110IBA
07/2005
1Humanized Monoclonal AntibodiesIBA
05/2005
1Fluorouracil (Carac)FDA LinkGeneric
04/2005
1Biological ProductsIBA
04/2005
1ORALIT (ORS)IBA
08/2004
1Floxuridine (FUdR)FDA LinkGeneric
01/2004
1Drug CarriersIBA
01/2004
1LigandsIBA
01/2004
1LipidsIBA
01/2004
1Indicators and Reagents (Reagents)IBA
01/2004
1AnthracyclinesIBA
12/2003
1AcidsIBA
09/2003
1Bispecific AntibodiesIBA
05/2002
1RNA (Ribonucleic Acid)IBA
05/2002
1Surface Antigens (Surface Antigen)IBA
05/2002

Therapy/Procedure

16Therapeutics
10/2009 - 05/2002
4Drug Therapy (Chemotherapy)
10/2009 - 04/2005
3Radioimmunotherapy
08/2005 - 03/2004
2Immunotherapy
02/2008 - 09/2007
1Treatment Delay
12/2005